|
1. Steuer AE, Schmidhauser C, Tingelhoff EH, Schmid Y, Rickli A, Kraemer T, et al. Impact of cytochrome P450 2D6 function on the chiral blood plasma pharmacokinetics of 3, 4-methylenedioxymethamphetamine (MDMA) and its phase I and II metabolites in humans. PloS One 2016; 11(3): e0150955. 2. Baumann MH, Rothman RB. Neural and cardiac toxicities associated with 3, 4-methylenediox-ymethamphetamine (MDMA). Int Rev Neurobiol 2009; 88: 257-96. 3. Desrosiers NA, Barnes AJ, Hartman RL, Scheidweiler KB, Kolbrich-Spargo EA, Gorelick DA, et al. Oral fluid and plasma 3, 4-methylenedioxymethamphetamine (MDMA) and metabolite correlation after controlled oral MDMA administration Anal Bioanal Chem 2013; 405(12): 4067-76. 4. Song BJ, Moon KH, Upreti VV, Eddington N D,Lee IJ. Mechanisms of MDMA (ecstasy)-induced oxidative stress, mitochondrial dysfunction, and organ damage. Curr Pharm Biotechnol 2010; 11(5): 434-43. 5. Capela JP, Carmo H, Remião F, Bastos ML, Meisel A,Carvalho F. Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. Mol Neurobiol 2009; 39(3): 210-71. 6. Guneysel O, Onur OE, Akoglu H, Denizbasi A. Ecstasy-induced recurrent toxic hepatitis in a young adult. Curr Ther Res Clin Exp 2008; 69(3): 260. 7. Barrett SP, Darredeau C, Pihl RO. Patterns of simultaneous polysubstance use in drug using university students. Hum Psychopharmacol 2006; 21(4): 255-63. 8. Tufan ZK, Bulut C, Kinikli S, Irmak H, Yilmaz GR, Demİröz AP. a case report of Ecstasy-induced acute hepatic failure. Turkish J Med Sci 2006; 36(5): 319-21. 9. Green ST, Frischer M, Taylor A, Goldberg DJ, McKeganey N,Bloor M.Increasing ecstasy use among Glasgow drug injectors. Taylor & Francis; 1995. 10. Burgess C, O’Donohoe A, Gill M. Agony and ecstasy: a review of MDMA effects and toxicity. Eur Psychiatry 2000; 15(5): 287-94. 11. Peraile I,Torres E,Mayado A,Izco M, Lopez-Jimenez A, Lopez-Moreno JA, Colado ML et al. Dopamine transporter down‐regulation following repeated cocaine: implications for 3, 4‐methylene-dioxymethamphetamine‐induced acute effects and long‐term neurotoxicity in mice. Br J Pharmacol 2010; 159(1): 201-11. 12. Steinkellner T, Freissmuth M, Sitte HH, Montgomery T. The ugly side of amphetamines: short-and long-term toxicity of 3, 4-methylenedioxymethamphetamine (MDMA,‘Ecstasy’), methamphetamine and D-amphetamine. Biol Chem 2011; 392(1-2): 103-15. 13. Kalant H. The pharmacology and toxicology of “ecstasy”(MDMA) and related drugs. CMAJ 2001; 165(7): 917-28. 14. Richman J, Ferber A. Severe aplastic anemia with hot pockets following daily Ecstasy ingestion. Am J Hematol 2008;83(4):321-2. 15. Swerdlow NR, Koob GF, Cador M, Lorang M, Hauger RL. Pituitary-adrenal axis responses to acute amphetamine in the rat. Pharmacol Biochem Behav 1993;45(3):629-37. 16. Walter T. Impact of iron deficiency on cognition in infancy and childhood. Eur J Clin Nut 1993; 47(5): 307-16. 17. Nakazawa Y, Yokoyama T, Kurauchi H, Ueda S, Sakamoto T, Imatoh N, et al. Folic acid in serum and cerebrospinal fluid of chronic alcoholics and methamphetamine addicts. Drug Alcohol Depend 1981; 7(2): 193-9. 18. Strohm EM, Berndl ES, Kolios MC. Probing red blood cell morphology using high-frequency photoacoustics. Biophys J 2013; 105(1): 59-67. 19. Fung YC. Mechanical properties and active remodeling of blood vessels. Biomechanics: Springer; 1993. p. 321-91. 20. Mary LB, Charles B. Clinical laboratory parameters for Crl: WI(Han). Charles River Laboratories 2008: 1-14. 21. Pan L, Wang X, Yang S, Wu X, Lee I, Zhang X, et al. Ultraviolet irradiation-dependent fluorescence enhancement of hemoglobin catalyzed by reactive oxygen species. Plos One 2012; 7(8): e44142. 22. Benton MC, Lea RA, Macartney-Coxson D, Bellis C, Carless MA Curran JE, et al. Serum bilirubin concentration is modified by UGT1A1 Haplotypes and influences risk of Type-2 diabetes in the Norfolk Island genetic isolate. BMC Genet 2015; 16: 136. 23. Zhou Y, Zhang C, Yao DK, Wang LV. Photoacoustic microscopy of bilirubin in tissue phantoms. J Biomed Opt 2012; 17(12): 126019. 24. Oussalah A, Bosco P, Anello G, Spada R, Gueant-Rodriguez RM, Chery C, et al. Exome-wide association study identifies new low-frequency and rare UGT1A1 coding variants and UGT1A6 coding variants influencing serum bilirubin in elderly subjects: a strobe compliant article. Med (Baltimore) 2015; 94(22): e925. 25. Gomez-Pinilla F. The influences of diet and exercise on mental health through hormesis. Ageing Res Rev 2008; 7(1): 49-62. 26. Khalaji N, Namyari M, Rasmi Y, Pourjabali M, Chodari L. Protective effect of curcumin on fertility of rats after exposure to compact fluorescent lamps: An experimental study. Int J Reprod BioMed 2018; 16(7): 447-54. 27. Khalaji N, Zeinali A, Purjabali M, Bolurani K, Fard AA. The Effect of Bioactive Component of Turmeric (curcumin) on Liver Complications - Induced by Compact Fluorescent Lamps (CFLs) in Rats. Shiraz E-Med J 2018; 19(4): e60572. 28. Ilbey YO, Ozbek E, Cekmen M, Simsek A, Otunctemur A, Somay A. Protective effect of curcumin in cisplatin-induced oxidative injury in rat testis: mitogen-activated protein kinase and nuclear factor-kappa B signaling pathways. Hum Reprod 2009; 24(7): 1717-25. 29. Khalaji N, Zeinali A, Purjabali M, Bolurani K, Fard AA. The Effect of Bioactive Component of Turmeric (curcumin) on Liver Complications-Induced by Compact Fluorescent Lamps (CFLs) in Rats. Shiraz E-Medical J 2018 (In Press). [in Persian] 30. Papież MA, Krzyściak W, Szade K, Bukowska-Straková K, Kozakowska M, Hajduk K, et al. Curcumin enhances the cytogenotoxic effect of etoposide in leukemia cells through induction of reactive oxygen species. Drug Des Devel Ther 2016; 10: 557-70. 31. Ding L, Li J, Huang R, Liu Z, Li C, Yao S, et al. Salvianolic acid B protects against myocardial damage caused by nanocarrier TiO2; and synergistic anti-breast carcinoma effect with curcumin via codelivery system of folic acid-targeted and polyethylene glycol-modified TiO2 nanoparticles. Int J nanomedicine 2016;11:5709-5727. 32. Connor TJ, Mc Namara MG, Finn D, Currid A, O’Malley M, Redmond AM.Acute3,4-methylenedioxy methamphetamine (MDMA) is toxic to neurons in the rat brain. J Pharmacol Exp Ther 1998;241:338-45. 33. House RV, Thomas PT, Bhargava HN. Comparison of immune functional parameters following in vitro exposure to natural and synthetic amphetamines. Immunopharmacol Immunotoxicol 1994; 16(1): 1-21. 34. Sharma RA1, Gescher AJ, Steward WP. Curcumin: the story so far. Eur J Cancer 2005; 41(13): 1955-68. 35. Sakai K, Miyazaki Y, Yamane T, Saitoh Y, Ikawa C, Nishihata T. Effect of extracts of Zingiberaceae herbs on gastric secretion in rabbits. Chem Pharm Bull (Tokyo). 1989; 37(1): 215-7. 36. Skelton MR, Williams MT, Vorhees CV. Developmental effects of 3, 4-methylenedioxy-methamphetamine: a review. Behav Pharmacol 2008; 19(2): 91-111. 37. Fani A, Ghasedi M, Esmaeelion F, Alizadeh B. The effect of curcuma on improvement of clinical symptom of patients with irritable bowel syndrome. Arak Med Univ J 2010; 13(3). [in Persian] 38. Rodgers GM 3rd, Becker PS, Blinder M, Cella D, Chanan-Khan A, Cleeland C, et al. Cancer-and chemotherapy-induced anemia. J Natl Compr Canc Netw 2012; 10(5): 628-53. 39. Guyton AC, Hall JE. Textbook of medical physiology. thirteenth Edition, Philadelphia; 2016. p. 429-49.
|
.png)
.png){kind=logo}
